Copyright
©The Author(s) 2021.
World J Gastrointest Pathophysiol. May 22, 2021; 12(3): 51-58
Published online May 22, 2021. doi: 10.4291/wjgp.v12.i3.51
Published online May 22, 2021. doi: 10.4291/wjgp.v12.i3.51
Total (%) | Reactivation (%) | RR (95%CI) | P value | |
Number of patients (%) | 72 (100) | 23 (32) | ||
Gender (male) | 21 (29.2) | 7 (33.3) | 1.09 (0.37-3.23) | 0.871 |
Mean age, years (SD) | 56.3 (9.6) | 57.3 (9.2) | NA | 0.900 |
MELD, median (IqR) | 12 (14) | 12 (12) | NA | 0.712 |
Lymphocyte count, median (IqR) | 929 (808) | 929 (770) | NA | 0.471 |
CMV receptor IgG-negative | 5 (8.7) | 2 (40) | 0.68 (0.11-4.40) | 0.652 |
HCV | 46 (63.9) | 15 (32.6) | 1.09 (0.39-3.1) | 0.872 |
HBV | 5 (6.9) | 1 (20) | 0.51 (0.05-4.9) | 1.000 |
Hepatocarcinoma | 42 (58.3) | 14 (33.3) | 1.17 (0.42-3.2) | 0.765 |
Fulminant hepatitis | 2 (3) | 0 | NA | NA |
Diabetes mellitus | 24 (33.3) | 8 (33.3) | 1.1 (0.38-3.13) | 0.858 |
Renal failure | 8 (11.1) | 5 (62.5) | 4.26 (0.92-19.7) | 0.100 |
Re-transplant | 2 (3) | 0 | NA | NA |
- Citation: Stadnik CMB, Caurio CFB, Rodrigues-Filho EM, Nedel WL, Cantisani GP, Zanotelli ML, Pasqualotto AC. Impact of cytomegalovirus reactivation just before liver transplantation: A prospective cohort study. World J Gastrointest Pathophysiol 2021; 12(3): 51-58
- URL: https://www.wjgnet.com/2150-5330/full/v12/i3/51.htm
- DOI: https://dx.doi.org/10.4291/wjgp.v12.i3.51